A share price of Q32 Bio Inc [QTTB] is currently trading at $2.99, up 18.65%. An important factor to consider is whether the stock is rising or falling in short-term value. The QTTB shares have gain 43.75% over the last week, with a monthly amount glided 67.98%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Q32 Bio Inc [NASDAQ: QTTB] stock has seen the most recent analyst activity on February 11, 2025, when Piper Sandler downgraded its rating to a Neutral and also revised its price target to $4 from $20. Previously, BMO Capital Markets downgraded its rating to Market Perform on February 11, 2025, and dropped its price target to $3. On December 11, 2024, downgrade downgraded it’s rating to Equal Weight and revised its price target to $16 on the stock. Raymond James downgraded its rating to a Outperform and decreased its price target to $22 on December 11, 2024. Leerink Partners downgraded its rating to a Market Perform and reduced its price target to $9 on December 11, 2024. Guggenheim downgraded its rating to Neutral for this stock on December 11, 2024. In a note dated December 06, 2024, BMO Capital Markets initiated an Outperform rating and provided a target price of $64 on this stock.
Q32 Bio Inc experienced fluctuations in its stock price throughout the past year between $1.35 and $53.17. Currently, Wall Street analysts expect the stock to reach $63.83 within the next 12 months. Q32 Bio Inc [NASDAQ: QTTB] shares were valued at $2.99 at the most recent close of the market. An investor can expect a potential return of 2034.78% based on the average QTTB price forecast.
Analyzing the QTTB fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.79, Equity is -27.1 and Total Capital is -1.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-1.53.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.73 points at the first support level, and at 2.46 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.23, and for the 2nd resistance point, it is at 3.46.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Q32 Bio Inc [NASDAQ:QTTB] is 5.06. On the other hand, the Quick Ratio is 5.06, and the Cash Ratio is 4.75.
Transactions by insiders
Recent insider trading involved Morrison Jodie Pope, CEO, that happened on Aug 26 ’25 when 10494.0 shares were sold. Chief Scientific Officer, Violette Shelia M. completed a deal on Aug 26 ’25 to sell 2990.0 shares. Meanwhile, CFO and President Kalowski Lee sold 4240.0 shares on Aug 26 ’25.
